news .bio

The Radiology Rundown: November Edition

Welcome to the November edition of The Radiology Rundown. With November ending, we all know what that brings…

RSNA 2024 Banner

Your flights are booked, your suitcase packed and your warm coat is at the ready (it’s meant to be even colder than last year). It’s time to preview this year’s RSNA.

Held at McCormick Place in Chicago, RSNA 2024 is expected to attract nearly 25,000 medical imaging professionals to the world’s largest medical equipment exhibition.

Over 750 exhibitors can be found in the vast halls of McCormick this year, alongside over 300 educational courses, and more than 2,800 scientific presentations.

Your itinerary for next week is probably looking quite full, but if you have a few time slots left, here are some picks from me on who you should make some time to meet.

CureMetrix

A shot of the cmAngio product identifying Breast Arterial Calcifications

First on my list is CureMetrix, with cmAngio®.

I had the pleasure of discussing cmAngio® with the CureMetrix team in November, and they should be high on your list of meetings for RSNA too.

This ground-breaking FDA-cleared AI software revolutionizes the identification of Breast Arterial Calcifications (BAC) in Full Field Digital Mammograms (FFDM) and Digital Breast Tomosynthesis (DBT) sans.

The first and only FDA-cleared product of its kind on the market, cmAngio® detects BAC at the study and breast level, marking BAC segments on mammogram thumbnails for precise localization. It enables physicians to identify BAC using existing screening mammograms, referring patients for further evaluation without additional radiation or procedures.

The cmAngio® Scorecard highlights BAC regions with contours on thumbnails, allowing quick visualization and reporting. By facilitating early detection of BAC, which might otherwise go unnoticed until serious symptoms arise, cmAngio® supports improved patient care and empowers radiologists to make more informed assessment and follow-up recommendations.

CureMetrix is hosting pre-scheduled meetings during RSNA, and you can book a meeting here. If you are not attending or unable to meet, please contact CureMetrix here.

Cerebriu

An image showing a brain scan

I first met the Cerebriu team at RSNA 2023, and if you didn’t meet them then, this should be the year you do.

Fresh off closing their Series A round in September, the Copenhagen-based innovator in MRI workflow is one to watch in 2025.

Founded in 2018, their Apollo product is the first CE-marked real-time MRI triage and automated protocol optimization solution for brain MRI.

With significant recognition across EMEA and a partnership with Siemens Healthineers, next year looks to be the year that Cerebriu makes big strides in North America as well.

To anyone involved in the Neuro space, Cerebriu’s Apollo product is a must-see at RSNA.

They can be found at booth 5519 at the AI Showcase in the South Hall. You can schedule some time to meet with them here.

CARPL.ai

The CARPL.ai logo

My third recommendation for RSNA 2024 is CARPL.ai.

The past 12 months have been outstanding for the Radiology AI platform company. From a seed funding round in February, to 510(k) clearance from the FDA in May, and CE Mark for Europe last month. CARPL.ai is arriving in Chicago with some serious momentum.

Boasting 135+ applications from 60+ vendors on their platform, they’re making big waves in competitive Radiology AI platform space.

CARPL.ai have a packed lineup of events at RSNA this year, including AI panel discussions, booth presentations and a presentation at the AI Theatre on Monday 2 December at 2.30pm.

You can book a meeting with the CARPL.ai team here – I know I already have.

An industry news heading banner

Industry News

Outside of RSNA, there have, of course, been some other major updates in the world of Medical Imaging this November.

Metric Bio client Butterfly Network received the Best Medical Technology award for 2024 at the Prix Galien USA Awards.

Regarded as the ‘Nobel Prize of Life Sciences’ this award for their iQ3 product is a real testament to the work and dedication of their team.

Butterfly Network is exhibiting at RSNA – you can find out more about iQ3 at booth 3972 in the South Hall.

Deepc also debuted their deepcOS AIR platform, with a live product launch last week.

Industry leader Dr. Amine Korchi described the launch best, as having an ‘Apple-like feel’ with Deepc ‘walking the ‘last mile of the radiology workflow…connecting AI software that analyzes images directly to reporting solutions that enhance radiology report generation.’

A possible gamechanger? I know Franz Pfister and Deepx team think so.

They can be found at booth 5347 in the AI Showcase selection of the South Hall at RSNA.

An FDA approvals heading banner

FDA Approvals

It’s been another busy month for market approvals.

Metric Bio partner Nicolab started the month by announcing their EU MDR and UK MDR regulatory approval.

Hyperfine announced their European launch, with CE Approval of their latest generation of AI-powered Swoop System software.

You can find them at booth 2802 in the South Hall at RSNA, where they will once again be offering live portable MR brain scans.

Icometrix received the first FDA clearance for AI-driven MRI solutions for Alzheimer’s treatment. You can find them at booth 4903 in the AI Showcase, South Hall.

Last week, TeraRecon received 510(k) clearance for their cardiac MR AI-based auto-contouring. They will be at booth 8134 in the North Hall.

And finally, Korean-based AI imaging company VUNO received FDA clearance for their chest X-ray product. They can also be found in the AI Showcase in the South Hall, at booth 4952.

A funding updates heading banner

Funding Announcements 

There are increasingly positive signs of continued investment in radiology across North America and Europe.

One of the biggest announcements in November was Cortechs.ai closing their oversubscribed Series C round. They can be found at booth 6551 in the North Hall at RSNA.

Ligence announced their second-round funding of €3m to support growth of their solution in the cardiac ultrasound AI space.

Their team will be at RSNA, and you can arrange to meet their Co-Founder and Chief Business Development Manager, Dovydas, here.

Mediaire confirmed their €12m growth investment to scale their operation in the AI imaging space.

A partnerships and acquisitions heading banner

Partnership and Acquisitions

A summary of the key partnerships that have been announced in November are:

Want The Radiology Rundown delivered straight to your inbox?

Join The Radiology Rundown community and register your details to receive The Radiology Rundown directly to your inbox via the form here.

news .bio
The Radiology Rundown: October Edition
news .bio
The Radiology Rundown: September Edition
news .bio
The Radiology Rundown: August Edition